Navigation Links
Co-Founder of Omega3 Innovations Says Today’s Fish Oil Industry is on the Wrong Track, Sets Up Blog to Help Consumers Understand Why
Date:1/15/2013

Venice, FL (PRWEB) January 15, 2013

For 16 years, Dr. Bo Martinsen – co-founder of Venice-based Omega3 Innovations – has championed omega-3 fish oils by touting the fatty acids’ numerous health benefits at both national and international speaking engagements.

“As a physician, I always tell my patients, if there is one simple thing you can do for your health, take a solid dose of omega-3 fish oil every day,” Martinsen says.

But recently, Martinsen, who co-owns the biotech company with Dr. Anne-Marie Chalmers, witnessed a growing trend in the industry – the market shift toward highly-concentrated fish oil supplements – that convinced him to alter his advice. As the market for fish oil grows, concentrates are becoming increasingly popular both in prescription and over-the-counter form.

A quick look around your local pharmacy shows the increasing presence of concentrated omega-3s, says Martinsen, who cites market growth projections of eight percent a year through 2020 (1).

And, the growth spurt in products created by this type of manufacturing process has him worried.

“I used to think that as long as we took an adequate dose of omega-3 every day, the type of oil didn’t matter,” he says. “But, the more I work with omega-3, the more I see that the quality and manufacturing process of the oil is crucial to consumer health.”

Martinsen says that some manufacturers – in an effort to increase the essential fatty acids EPA and DHA in the fish oil – transform the acids into new chemical structures known as ethyl esters. He notes that ethyl esters exist neither in nature, nor in the human body.

His research on chemically modified omega-3s versus natural fish oils has led him to create a blog titled “Seven Reasons the Omega-3 Industry is on the Wrong Track.”

“When we start changing the chemical structure of the omega-3 molecules, the body responds differently to the modified oil than it does to natural fish oil,” he explains. “Just like with genetically modified organisms, these chemical modifications are troubling because we don’t know how the body will fully respond for years.”

Martinsen says some other negative issues with concentrated omega-3s are rancidity, fewer fatty acids and natural vitamins, environmental waste, and the fact that they can be more expensive.

“The fact is that people can get the same amount of EPA and DHA from natural sources as is advertised in the concentrated products,” he says. “I believe we would all benefit greatly if the industry focused instead on improving the technology for making liquid fish oil that is fresh and sustainable.”

Reference
1. Matthews, Sheenagh. “BASF to Pay $654 Million for Pronova to be Leader in Omega-3.” Bloomberg.com. Nov. 21, 2012.

For more information about this release, please contact:
Anne-Marie Chalmers, M.D., Omega3 Innovations, 941-485-4400 or am(at)omega3innovations(dot)com
Bo Martinsen, M.D., Omega3 Innovations, 941-485-4400 or bo(at)omega3innovations(dot)com
Charlene Hager-Van Dyke, Larry Vershel Communications, 407-644-4142, 386-532-8862, or chagervandyke(at)yahoo(dot)com

Read the full story at http://www.prweb.com/releases/2013/1/prweb10301066.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Omega3 Innovations Helps Local Food Bank Provide Thanksgiving Dinners for those in Need
2. Invisalign® Available at Smile Innovations
3. Smile Innovations Announces New Care Credit Payment Option for Clients
4. MSU invention could help pharmaceutical industry save money
5. More cutting-edge cancer research supported by industry
6. Ultra-short laser pulses for science and industry
7. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
8. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
9. Advertising Industry Veteran Pat McCrossan Joins Mangos
10. Trivedi Beef, LLC Announces Breakthrough Beef Industry Data without the use of Antibiotic Drugs, Hormones or Steroids
11. QTrade's New Facility Anticipates Dramatic Growth of Tea Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Paul Vitenas, MD, FACS , ... Top Doctor. The annual list identifies the nation’s top physicians, in a variety of ... it to the top of Castle Connolly’s coveted ranking. , Castle Connolly is the ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards of Infection ... reprocessing cycle, both between patient procedures and before storage, is a requisite practice ... important to the prevention of disease transmission and nosocomial infection as cleaning and ...
(Date:8/16/2017)... ... 16, 2017 , ... Richard Strawn’s new book Surgical ... of a cancer diagnosis, surgery and recovery, the Psalms provided encouragement and hope, ... God shows love to those who are sick., Surgical Psalms contains 36 reflections ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... an opportunity for men and women to train as hospice volunteers. Volunteers provide ... life-limiting illness. For over 30 years, the agency has trained volunteers to be ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... and marketers of high-quality anti-aging skincare solutions, recently announced the launch of two ... are an affordable, yet effective alternative to expensive plastic surgery or in-patient cosmetic ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... OCEANSIDE, Calif. , Aug. 15, 2017  AOTI Inc. announced ... Advanced Oxygen Therapy Inc., has recently opened a New York City ... the ever-increasing usage of its unique Topical Wound Oxygen (TWO 2 ... approved by the Accreditation Commission for Health Care (ACHC) under the ... ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 million ... continuing operations Second-quarter 2017 ... million Second-quarter 2017 Sterile ... Second-quarter 2017 adjusted diluted earnings ... to $0.93 Second-quarter 2017 ...
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc (NASDAQ: ... agreements to resolve virtually all known U.S. mesh product ... to resolve the known remaining U.S. claims at reasonable ... beginning in the fourth quarter of 2017 and continuing ... its second quarter 2017 results, the Company intends to ...
Breaking Medicine Technology: